NCT03392116View on ClinicalTrials.gov

Single and Multiple Ascending Dose Study of NGM120 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

January 29, 2018

Primary Completion Date

January 14, 2019

Study Completion Date

March 11, 2019

Conditions
Cachexia
Interventions
BIOLOGICAL

NGM120

Subcutaneous Injection

OTHER

Placebo

Subcutaneous Injection

Trial Locations (1)

Unknown

Nucleus Network Limited, Melbourne

Sponsors
All Listed Sponsors
lead

NGM Biopharmaceuticals, Inc

INDUSTRY